HR17031 clinical trials
How each study uses HR17031 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses HR17031 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- A Trial of HR17031 Injection With Renal InsufficiencyCompletedPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT05292495Written as HR17031 injection
- A Study Comparing HR17031 With Insulin Glargine in Patients With Type 2 DiabetesCompletedPhase 3Jiangsu HengRui Medicine Co., Ltd.NCT06881264Written as HR17031 injection
- A Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 DiabetesCompletedPhase 3Jiangsu HengRui Medicine Co., Ltd.NCT06871761Written as HR17031 injection
- A Clinical Study to Compare the Bioavailability of HR17031 in Healthy Subjects at Different SitesCompletedPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT06086912Written as HR17031
- A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 DiabetesStatus unknownPhase 2Jiangsu HengRui Medicine Co., Ltd.NCT05333835Written as HR17031 injection
- Pharmacokinetics of HR17031 Injection in Healthy SubjectsCompletedPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT05031871Written as HR17031 injection ;INS068 injection;SHR20004 injection
- A Trial of HR17031 Injection With Hepatic InsufficiencyStatus unknownPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT05151705Written as HR17031 injection